<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2011</study_start_year><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><data_sharing_plan>IPD Sharing (as of July 2016): No</data_sharing_plan><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2104101</full_dataset_link><location>China</location><study_start_month>3</study_start_month><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>An Observational Study of Bevacizumab in Combination With 5-FU-Based Chemotherapy in Chinese Participants With Metastatic Colorectal Cancer</name><description>This observational study will evaluate the safety and efficacy of Bevacizumab in combination with 5-Fluorouracil based chemotherapy as first-line and second-line therapy in Chinese participants with metastatic colorectal cancer. Data will be collected from each participant for up to 3 years.</description><dates><creation>2011-03-15</creation></dates><accession>2104101</accession><cross_references><ClinicalTrials___gov>NCT01319877</ClinicalTrials___gov></cross_references></HashMap>